Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.

Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Máximo V, Botelho T, Seruca R, Sobrinho-Simões M.

Oncogene. 2003 Jul 17;22(29):4578-80.

PMID:
12881714
2.
3.

Cancer after nuclear fallout: lessons from the Chernobyl accident.

Williams D.

Nat Rev Cancer. 2002 Jul;2(7):543-9. Review. No abstract available.

PMID:
12094241
4.

Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma.

Basolo F, Giannini R, Monaco C, Melillo RM, Carlomagno F, Pancrazi M, Salvatore G, Chiappetta G, Pacini F, Elisei R, Miccoli P, Pinchera A, Fusco A, Santoro M.

Am J Pathol. 2002 Jan;160(1):247-54.

5.

Thyroid tumor banks.

Thomas GA, Williams ED.

Science. 2000 Sep 29;289(5488):2283. No abstract available.

PMID:
11041794
6.

Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.

Rabes HM, Demidchik EP, Sidorow JD, Lengfelder E, Beimfohr C, Hoelzel D, Klugbauer S.

Clin Cancer Res. 2000 Mar;6(3):1093-103.

8.

High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant.

Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, Cherstvoy ED, Tronko ND, Bogdanova TI, Chiappetta G, Viglietto G, Pentimalli F, Salvatore G, Fusco A, Santoro M, Vecchio G.

J Clin Endocrinol Metab. 1999 Nov;84(11):4232-8.

PMID:
10566678
9.

Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: statistical data and clinicomorphologic characteristics.

Tronko MD, Bogdanova TI, Komissarenko IV, Epstein OV, Oliynyk V, Kovalenko A, Likhtarev IA, Kairo I, Peters SB, LiVolsi VA.

Cancer. 1999 Jul 1;86(1):149-56.

PMID:
10391575
10.

The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.

Powell DJ Jr, Russell J, Nibu K, Li G, Rhee E, Liao M, Goldstein M, Keane WM, Santoro M, Fusco A, Rothstein JL.

Cancer Res. 1998 Dec 1;58(23):5523-8.

11.
12.

Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.

Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G, Fusco A.

Oncogene. 1996 Apr 18;12(8):1821-6.

PMID:
8622903
14.

Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies.

Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr.

Radiat Res. 1995 Mar;141(3):259-77.

PMID:
7871153
15.

Childhood thyroid cancer in England and Wales.

Harach HR, Williams ED.

Br J Cancer. 1995 Sep;72(3):777-83.

16.

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della Porta G, Berger N, et al.

J Clin Invest. 1992 May;89(5):1517-22.

17.

Thyroid cancer after Chernobyl.

Baverstock K, Egloff B, Pinchera A, Ruchti C, Williams D.

Nature. 1992 Sep 3;359(6390):21-2. No abstract available.

PMID:
1522880
18.

Thyroid cancer after Chernobyl.

Kazakov VS, Demidchik EP, Astakhova LN.

Nature. 1992 Sep 3;359(6390):21. No abstract available.

PMID:
1522879
19.

Pathomorphological findings in thyroid cancers of children from the Republic of Belarus: a study of 86 cases occurring between 1986 ('post-Chernobyl') and 1991.

Furmanchuk AW, Averkin JI, Egloff B, Ruchti C, Abelin T, Schäppi W, Korotkevich EA.

Histopathology. 1992 Nov;21(5):401-8.

PMID:
1452122
Items per page

Supplemental Content

Write to the Help Desk